pharmaceutical distribution: ensuring product integrity and patient safety mike broughton,...
TRANSCRIPT
Pharmaceutical Distribution: Ensuring Product Integrity and Patient Safety
Mike Broughton, Distribution Operations21st Century Transport Logistics SummitIndianapolis, IN 19 October 2005
USA Distribution Operations
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
2
• Is distribution a core competency at your company?
• Does the distribution of our products provide a competitive advantage?
• Are there others that could pick, pack, store and ship product cheaper?
A: Ensure product integrity to assure product safety and patient safety
Pharmaceutical Distribution Strategic Questions
Lilly is set to open it’s new US Distribution Center in Plainfield this November! Lilly is set to open it’s new US Distribution Center in Plainfield this November!
Tra
ditio
nal
Q: What is the strategic imperative related to distribution?
Ne
w
Strategic Questions
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
3
Insulin Vial Supply Chain
= Lilly Node
= Affiliates
= Non-Lilly Node
Bulk Site
Form Sites Finish Sites End Markets
Indianapolis
Humulin BulkCrystals (BHI)
Fegersheim
GiessenRDC
Fegersheim
Seishin, Japan
Spain
Japan
Lilly Mexico
Indianapolis
Lilly Egypt, Cairo
MJPL, India
Human, Hungary
Human, Hungary
MJPL, India
Giessen
Alcobendas
Lilly Brazil
Indianapolis
Lilly Egypt
Brazil
Hungary (U40)
India
U100 10ml
U100 10ml
U100 & U40 – 10ml
U40 R, N,70/30, 50/50
U40, U100
U100 (4ml, 10ml), U40
BelgiumGermanyNetherlands
Austria Latvia RomaniaBulgaria LithuaniaCzech Rep. SloveniaBosnia & Herzegovina
Philippines Philippines
ArgentinaBoliviaCentral AmericaChileColombiaDominican RepEcuador
MexicoParaguayPeruUruguayVenezuelaWIZ (in 2005) Aruba
BahamasBahrainBarbadosBermudaCanadaCaymen Is.Cocos(Keeling) Is.CyprusFijiGrenadaGuamHaitiJamaicaJordanKuwait
LebanonMarshall Is.N. Mariana Is. OmanPapua New GuineaPuerto RicoQatarSaudi ArabiaSt. LuciaSyriaTrinidadUAEUSVirgin Is.Yemen
AustraliaBelgiumCanadaEstoniaEthiopiaFinlandGhanaGreeceKenyaS. Korea
LuxembourgMalaysiaMauritiusNew ZealandNorwaySingaporeSwedenTaiwanTanzaniaThailandUganda
AlgeriaArmeniaAzerbaijanBangladeshBahrainBelarusBotswanaBurkina FasoCameroonCent. African Rep.ChinaCongoCote D’IvoireDenmarkDjiboutiFranceGabonGeorgiaHong KongHungaryIcelandIndonesiaIrelandIsraelItalyIvory CoastKazakhstanKuwaitKyrgystanMozambiqueNambia
Libyan Arab JamahiryaNetherlandsNigeriaPakistanPalestinePhilippinesPolandPortugalRussiaSamoaSlovakiaSloveniaS. AfricaS. KoreaSpainSri LankaSvalbard & Jan MayenSwazilandSwitzerlandTongaTunisiaTurkeyUkraineUAEUKUzbekistanVietnamYemenZimbabwe
Hospira, US
U100 R (N in ‘06)
Egypt Pakistan KenyaBangladesh S. Africa
Lilly Mexico
EU in ‘0
4
US Only
Farmak Ukraine
Sothema, MoroccoSothema, Mor Morocco
Ensuring product integrity around the globe!
Ensuring product integrity around the globe!
Insulin Shipments from Indianapolis
Temperature monitoring
Destination: Columbia
Destination: Columbia
Destination: Mexico
Destination: Mexico
Destination: Brazil
Destination: Brazil
Destination: Bahrain
Destination: Bahrain
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
5
BulkBulk Form/FillForm/Fill FinishFinish DistributionDistribution
Securing the Supply Chain and Distribution
Relatively Secure
Product “At Risk”
There are a number of internal safeguards to protect product while it is within Lilly’s control
facilities.
There are a number of internal safeguards to protect product while it is within Lilly’s control
facilities.
DoctorDoctor
PayorEmployer /
HMO
PayorEmployer /
HMO
PatientPatient
WholesalerWholesaler
Drug ChainsPharmacy
Drug ChainsPharmacy
PBM/Mail-orderPharmacy
PBM/Mail-orderPharmacy
Sales ForceSales Force
InstitutionInstitution
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
6
Every single code is unique
Non re-occurring
Encrypted
Mass Serialization: Security Codes
Mass Serialization at the item level will be essential to the Pharma industry in the future…
Mass serialization involves assigning a code to each individual item produced: pallet, case and item level coding - such codes must be unique and impossible to guess.
The FDA has concluded that mass serialization is “the single most powerful tool available to secure the U.S. drug supply.”
- FDA, “Combating Counterfeit Drugs”, February 2004
The FDA has concluded that mass serialization is “the single most powerful tool available to secure the U.S. drug supply.”
- FDA, “Combating Counterfeit Drugs”, February 2004
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
7
Pharmacy
Wholesaler
PharmaManufacturers
apply RFID tags
CentralDatabase
Chain Drug StoreDistribution Centers
Hospitals
The FDA’s vision of an Electronic Pedigree21.203D2A9.16E8B8.719BAE03C
Version — 8 bitsMfg. — 28 bits(> 268 Million)
Product Class — 24 bits(> 16 million)
Serial Number — 36 bits(> 68 billion)
21.203D2A9.16E8B8.719BAE03C
Version — 8 bitsMfg. — 28 bits(> 268 Million)
Product Class — 24 bits(> 16 million)
Serial Number — 36 bits(> 68 billion)
RFID Electronic Records:Receipt and Ship Dates
RegulatoryAgency
There are a number of
unanswered, complex
questions regarding electronic
product code standards, IT infrastructure, privacy, etc!!
There are a number of
unanswered, complex
questions regarding electronic
product code standards, IT infrastructure, privacy, etc!!
Electronic Pedigree
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
8
Pedigree Developments in Europe
Serial Numbering – Sequential Coding in Europe• Application of unique number to item level • Communication of applied numbers to central database • Control of central database by national Ministry of Health
Drivers• Cost control of Health Care system• Track & Trace products through entire pharma supply chain• Avoid counterfeits and theft• Increase patient safety
Countries involved, status and main driver • Belgium: Implemented, reimbursement fraud• Italy: Partly implemented, cost control and counterfeits• Portugal: New requirement, cost control • Russia: New requirement - patient safety , cost control• Spain and others to follow
Mass Serialization: Europe
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
9
Enhanced communications via the following sources: •EDI capabilities •E-Mail•Direct Link Access •Internet Access •FastFax Reporting •Load Tracing and Tendering via the Internet
The Future: Real Time visibility
Best-in-class Examples
Cargo and Position reports
Photo sources: Envirotainer/DHL, Qualcomm, Prime Carriers
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
10
Opportunities for Indiana?…
• Track and Trace technologies • Electronic Pedigrees – database security,
information sharing• Cold Chain Management – packaging and shipping
containers• Distribution hub – it’s hard to believe… there is
currently no wholesale pharma distribution operation in the state!
• Indianapolis Airport: A viable alternative to congested ports for high priced (e.g. pharmaceutical) products from China and India
Conclusion
“The biggest single external element influencing pharmaceutical distribution operations concerns all the issues surrounding quality, security and validation processes.”
- Pharmaceutical Industry Analyst
“The biggest single external element influencing pharmaceutical distribution operations concerns all the issues surrounding quality, security and validation processes.”
- Pharmaceutical Industry Analyst
Back-up Slides
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
12
Distribution Strategy: What needs to be addressed? Now and in the future...
• Regulatory focus on distribution is increasing• More GMP / validation efforts • Cold-Chain• Pedigree requirements
• Security/Product Safety in handling and transport becoming more important
• # of SKUs could grow significantly due to country-specifc tagging serialization requirements
• Changes in product portfolios drive storage space requirements• Shift towards application devices/pens ongoing • E.g. Humalog, based on Insulin Equivalents: Vials (1) Cartridges (4x) Disposable
Pens (7x)• Special picking areas for special security substances
• Supply Chain Management• Product flows need to be tightly controlled• Importance increases with EU accession
Eli Lilly – Indiana Logistics Summit19 Oct 2005
Company ConfidentialCopyright © 2005 Eli Lilly and Company
13
Italy: General Overview
Italian MoH published new decree on Jan 4th 2005
Italian MoH has established a central database to track pharmaceutical products
Initial communication with central database via internet
Long term goal is to track & trace products through the entire supply chain from manufacturer to patient
Control of health care expense and improvement of patient safety
Mass Serialization: Europe